Glycans, essential components of glycoproteins and glycolipids, play pivotal roles in cellular communication and signaling within the nervous system. Recent studies highlight their potential as biomarkers for traumatic brain injury (TBI), offering insights into the pathophysiological mechanisms and aiding in early diagnosis. This abstract explores the emerging role of glycans in TBI diagnostics, emphasizing their promise in enhancing clinical assessment and management strategies for improved patient outcomes.
HTML PDFShare this article
Journal of Trauma & Treatment received 1048 citations as per Google Scholar report
